Cargando…

Toxicity and Disease-Related Outcomes after Radiotherapy for Head and Neck Cancer in Human Immunodeficiency Virus-Positive Patients

Background: Human immunodeficiency virus (HIV) seropositivity may be associated with higher risk of local recurrence and poor survival in multiple malignancies. However, long-term disease control in HIV-positive patients with head and neck cancer (HNC) is not well described. The purpose of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grew, David J., Cooper, Benjamin T., Nguy, Susanna, Halperin, Jason, Sanfilippo, Nicholas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226241/ https://www.ncbi.nlm.nih.gov/pubmed/25426448 http://dx.doi.org/10.3389/fonc.2014.00316

Ejemplares similares

PET/CT in Radiotherapy Planning for Head and Neck Cancer
por: Newbold, Katie, et al.
Publicado: (2012)

Radiomics and Machine Learning for Radiotherapy in Head and Neck Cancers
por: Giraud, Paul, et al.
Publicado: (2019)

Image-Guided Radiotherapy for Locally Advanced Head and Neck Cancer
por: Nguyen, Nam P., et al.
Publicado: (2013)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
por: Laursen, Michael, et al.
Publicado: (2018)

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma
por: Van Gestel, Dirk, et al.
Publicado: (2020)

Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges
por: Qian, Jack M., et al.
Publicado: (2021)

A Comparison of the Toxicities in Patients With Locally Advanced Head and Neck Cancers Treated With Concomitant Boost Radiotherapy Versus Conventional Chemoradiation
por: Sharma, Ritu, et al.
Publicado: (2023)

Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers
por: Espinosa, Maria L., et al.
Publicado: (2021)

ED visits, hospital admissions and treatment breaks in head/neck cancer patients undergoing radiotherapy
por: Patel, Shareen, et al.
Publicado: (2023)

Utilization of custom electron bolus in head and neck radiotherapy
por: Kudchadker, R. J., et al.
Publicado: (2003)

Predictive Biomarkers for Response and Toxicity of Induction Chemotherapy in Head and Neck Cancers
por: Boguszewicz, Łukasz
Publicado: (2022)

Initial experience of radiotherapy plus cetuximab for Japanese head and neck cancer patients
por: Kurokawa, Marie, et al.
Publicado: (2015)

The Impact of Clinical Trial Quality Assurance on Outcome in Head and Neck Radiotherapy Treatment
por: Zhong, Haoyu, et al.
Publicado: (2019)

Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study
por: Onjukka, Eva, et al.
Publicado: (2020)

Radiotherapy for Head and Neck Cancer: Evaluation of Triggered Adaptive Replanning in Routine Practice
por: Figen, Metin, et al.
Publicado: (2020)

Individualized 3D-Printed Tissue Retraction Devices for Head and Neck Radiotherapy
por: Herpel, Christopher, et al.
Publicado: (2021)

MR-Guided Radiotherapy for Head and Neck Cancer: Current Developments, Perspectives, and Challenges
por: Boeke, Simon, et al.
Publicado: (2021)

Brain and Head-and-Neck MRI in Immobilization Mask: A Practical Solution for MR-Only Radiotherapy
por: Mandija, Stefano, et al.
Publicado: (2019)

Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer
por: Nakata, Kensei, et al.
Publicado: (2013)

Impact of Magnetic Field on Dose Distribution in MR-Guided Radiotherapy of Head and Neck Cancer
por: Xia, Wenlong, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy as Primary Treatment for Elderly Patients with Medically Inoperable Head and Neck Cancer
por: Vargo, John A., et al.
Publicado: (2014)

Stereotactic Body Radiotherapy as Primary Therapy for Head and Neck Cancer in the Elderly or Patients with Poor Performance
por: Amini, Arya, et al.
Publicado: (2014)

Corrigendum: Impact of Magnetic Field on Dose Distribution in MR-Guided Radiotherapy of Head and Neck Cancer
por: Xia, Wenlong, et al.
Publicado: (2020)

Risk of CVD Following Radiotherapy for Head and Neck Cancer: An Updated Systematic Review and Meta-Analysis
por: Lin, Ping-Yi, et al.
Publicado: (2022)

Online daily assessment of dose change in head and neck radiotherapy without dose‐recalculation
por: Vickress, Jason R., et al.
Publicado: (2018)

Dose distribution prediction for head-and-neck cancer radiotherapy using a generative adversarial network: influence of input data
por: Gu, Xiaojin, et al.
Publicado: (2023)

Clinical Outcomes of Spatially Fractionated GRID Radiotherapy in the Treatment of Bulky Tumors of the Head and Neck
por: Choi, J. Isabelle, et al.
Publicado: (2019)

Inter-Observer Variation in Delineating the Pharyngeal Constrictor Muscle as Organ at Risk in Radiotherapy for Head and Neck Cancer
por: Petkar, Imran, et al.
Publicado: (2021)

Hypofractionated Radiotherapy in Head and Neck Cancer Elderly Patients: A Feasibility and Safety Systematic Review for the Clinician
por: Piras, Antonio, et al.
Publicado: (2021)

Retrospective Clinical Evaluation of a Decision-Support Software for Adaptive Radiotherapy of Head and Neck Cancer Patients
por: Gros, Sebastien A. A., et al.
Publicado: (2022)

Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning
por: Lucido, J. John, et al.
Publicado: (2023)

Early-onset dropped head syndrome after radiotherapy for head and neck cancer: dose constraints for neck extensor muscles
por: Inaba, Koji, et al.
Publicado: (2016)

Development and dosimetric verification of 3D customized bolus in head and neck radiotherapy
por: Chatchumnan, Nichakan, et al.
Publicado: (2022)

Development of an optimum photon beam model for head‐and‐neck intensity‐modulated radiotherapy
por: Webster, Gareth J, et al.
Publicado: (2007)

Penile cancer with positive nodes: A case of HPV p16-positivity and its significance, implication of data from head and neck cancer
por: Nguyen, Cam, et al.
Publicado: (2019)

A Study Comparing Acute Toxicities of Cetuximab and Cisplatin in Patients Undergoing Definitive Chemoradiation With Intensity-Modulated Radiotherapy for Locally Advanced Carcinoma Head and Neck
por: Venkateshulu, Shruthi, et al.
Publicado: (2021)

Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK
por: Uozumi, Shinya, et al.
Publicado: (2018)

Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab
por: Wu, Qiuji, et al.
Publicado: (2021)

Dosimetric and geometric evaluation of the use of deformable image registration in adaptive intensity-modulated radiotherapy for head-and-neck cancer
por: Eiland, R.B., et al.
Publicado: (2014)

Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation
por: van der Heijden, Martijn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_26csp5ghtbe25o6rm9l47klbnf